Adverum Biotechnologies
Adverum Biotechnologies Logo
About Adverum Biotechnologies
Adverum Biotechnologies Inc is a clinical-stage biotechnology company focused on developing gene therapy product candidates to address unmet medical needs in serious ocular and rare diseases. Its lead candidate, ixoberogene soroparvovec (ADVM-022), is being evaluated as a one-time intravitreal injection for the treatment of wet age-related macular degeneration and diabetic macular edema. The company is also developing ADVM-062 for blue cone monochromacy. Adverum aims to establish gene therapy as a new standard of care for debilitating retinal diseases.
Address
100 Cardinal Way,
Redwood City, 94063
United States
Year founded
2006
Number of employees
100-200
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
